What the Options Market Tells Us About AbbVie - AbbVie (NYSE:ABBV)

Core Insights - Investors are showing a bullish sentiment towards AbbVie (NYSE:ABBV), with significant options trading activity indicating potential upcoming developments [1][2] - The overall sentiment among large traders is 69% bullish and 30% bearish, with a total of $1.16 million in options trades identified [2] - The targeted price range for AbbVie over the last three months is between $170.0 and $225.0, based on volume and open interest analysis [3] Options Activity - The average open interest for AbbVie options is 1,766.69, with total trading volume reaching 3,346.00 in the last 30 days [4] - Notable options trades include a mix of calls and puts, with significant amounts allocated to both bullish and bearish positions [10] Company Overview - AbbVie is a pharmaceutical company with a strong focus on immunology and oncology, having expanded its portfolio through acquisitions, including Allergan in 2020 and recent acquisitions in neuroscience and oncology [11] - Analysts have set an average target price of $259.0 for AbbVie, with varying ratings from different firms, indicating a generally positive outlook [13][14] Current Market Position - AbbVie is currently trading at $215.9, reflecting a decrease of 0.98%, with a trading volume of 2,126,342 [16]